Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review
出版年份 2011 全文链接
标题
Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review
作者
关键词
-
出版物
HEPATOLOGY
Volume 54, Issue 2, Pages E1-E9
出版商
Wiley
发表日期
2011-07-27
DOI
10.1002/hep.24473
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B
- (2010) H. L.-Y. Chan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A Randomized Trial of Peginterferon α-2a With or Without Ribavirin for HBeAg-Negative Chronic Hepatitis B
- (2010) Vincent Rijckborst et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Hepatitis B surface antigen seroclearance during chronic HBV infection
- (2010) Chia-Ming Chu et al. ANTIVIRAL THERAPY
- Hepatitis B Surface Antigen (HBsAg): A 40-Year-Old Hepatitis B Virus Seromarker Gets New Life
- (2010) Brian J. McMahon GASTROENTEROLOGY
- Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers
- (2010) Maurizia Rossana Brunetto et al. GASTROENTEROLOGY
- Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
- (2010) E. Jenny Heathcote et al. GASTROENTEROLOGY
- Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels
- (2010) Vincent Rijckborst et al. HEPATOLOGY
- A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B
- (2010) Henry Lik-Yuen Chan et al. HEPATOLOGY
- Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline
- (2010) Milan J. Sonneveld et al. HEPATOLOGY
- Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients
- (2010) Karsten Wursthorn et al. HEPATOLOGY
- Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers
- (2010) Alexander J.V. Thompson et al. HEPATOLOGY
- Further analysis is required to identify an early stopping rule for peginterferon therapy that is valid for all hepatitis B e antigen-positive patients
- (2010) Teerha Piratvisuth et al. HEPATOLOGY
- Change in Serum Hepatitis B Surface Antigen Level and Its Clinical Significance in Treatment-naïve, Hepatitis B e Antigen-positive Patients Receiving Entecavir
- (2010) Young Kul Jung et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients
- (2010) Wei Cai et al. JOURNAL OF CLINICAL VIROLOGY
- Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa-2b in HBeAg-positive patients
- (2010) Hui Ma et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- 13 TELBIVUDINE (LDT) PLUS PEG-INTERFERON (PEGIFN) IN HBEAG-POSITIVE CHRONIC HEPATITIS B – VERY POTENT ANTIVIRAL EFFICACY BUT RISK OF PERIPHERAL NEUROPATHY (PN)
- (2010) P. Marcellin et al. JOURNAL OF HEPATOLOGY
- 1012 TELBIVUDINE-INDUCED HBEAG SEROCONVERSION IN CHRONIC HEPATITIS B (CHB) IS DURABLE DURING 2 YEARS OFF-TREATMENT FOLLOW-UP
- (2010) Y.-F. Liaw et al. JOURNAL OF HEPATOLOGY
- 1006 HBSAG KINETICS OF DECAY AND BASELINE CHARACTERISTICS OF HBEAG-POSITIVE PATIENTS WITH CHRONIC HEPATITIS B FOLLOWING 3 YEARS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT
- (2010) E. Gane et al. JOURNAL OF HEPATOLOGY
- Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia
- (2010) Tin Nguyen et al. JOURNAL OF HEPATOLOGY
- A new role for an old marker, HBsAg
- (2010) Maurizia Rossana Brunetto JOURNAL OF HEPATOLOGY
- Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective
- (2010) Jerzy Jaroszewicz et al. JOURNAL OF HEPATOLOGY
- Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir
- (2010) Jurriën G.P. Reijnders et al. JOURNAL OF HEPATOLOGY
- HBsAg Profiles in Patients Receiving Peginterferon Alfa‐2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses
- (2010) Ming‐Lung Yu et al. JOURNAL OF INFECTIOUS DISEASES
- Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-α2a
- (2009) Rami Moucari et al. ANTIVIRAL THERAPY
- Hepatitis B surface antigen quantification as a current-day paradox: Obtaining the gold in the face of diminishing returns
- (2009) Robert P. Perrillo HEPATOLOGY
- Chronic hepatitis B: Update 2009
- (2009) Anna S. F. Lok et al. HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
- (2009) JOURNAL OF HEPATOLOGY
- Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B*
- (2009) R. G. Gish et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis B virus infection
- (2009) Yun-Fan Liaw et al. LANCET
- Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients
- (2008) Rami Moucari et al. HEPATOLOGY
- Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B
- (2008) Maurizia Rossana Brunetto et al. HEPATOLOGY
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
- (2008) Yun-Fan Liaw et al. Hepatology International
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started